Skip to content

application of technologies for QFR and RWS based on DSA in the evaluation of carotid atherosclerotic stenosis function and plaque stability of patients with carotid atherosclerotic stenosis

Establishment and application of technologies and systems for artificial intelligence based on DSA in the evaluation of carotid atherosclerotic stenosis function and plaque stability of patients with carotid atherosclerotic stenosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094665
Enrollment
Unknown
Registered
2024-12-25
Start date
2022-09-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carotid artery atherosclerotic stenosis

Interventions

Fractional Flow Reserve,FFR:NA

Sponsors

Ordos Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Moderate to severe stenosis of the internal carotid artery (50%-99%) and confirmed by DSA examination; (2) Age> 18 years old; (3) The etiology is considered atherosclerosis, and there are risk factors for atherosclerosis, including hypertension, hyperlipidemia, diabetes, coronary heart disease, obesity and smoking, etc.; (4) Not treated with endovascular stenting. (5) The subject himself or legal representative is able to sign the informed consent form

Exclusion criteria

Exclusion criteria: (1) Multiple moderate to severe stenosis of intracranial arteries and extracranial arteries (>50%); (2) Extremely tortuous cerebrovascular lesions (guidewires cannot be operated); (3) There is an aneurysm lesion at the proximal or distal end of the stenotic lesion, which is cardiogenic embolic evidence; (4) Patients with a history of contrast allergy or renal failure; (5) pregnancy; (6) Chronic occlusion, tandem stenosis, and poor angiography image quality and hindering high-quality QFR analysis or the technical parameters of the CTP; (7) Severe overlap or distortion of target blood vessels; (8) patients who cannot obtain informed consent; (9) Contrast-enhanced MRI or CT examination is contraindicated (pacemaker, metal implant into, severe claustrophobia, pregnancy pregnancy, allergy, or glomerular filtration rate <30 mL/min/1.73 m^2); (10) Presence of contraindications to heparin, aspirin or other antiplatelet drugs; (11) Presence of non-atherosclerotic intracranial vascular lesions, such as arterial clips layers, vasculitic lesions, smoke sickness, etc.; (12) The expected survival time of the patient < 2 years; (13) Presence of cranial tumor, atrial fibrillation, aortic stenosis, and aorta Dissection, aortic aneurysm and other risks and diseases of vital organs.

Design outcomes

Primary

MeasureTime frame
Fractional Flow Reserve,FFR;Quantitative Flow Ratio,QFR;Radial wall strain,RWS;

Countries

China

Contacts

Public ContactWu Yinchun

Ordos Central Hospital

czwl1221@126.com+86 150 4770 9444

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026